Tres Alchemix

Japan
Fukuoka, Fukuoka, Japan

Company profile

Tres Alchemix company profile

Tres Alchemix is an AI-driven biotechnology company focused on accelerating drug discovery, predicting drug efficacy, and developing novel therapeutic compounds using advanced machine learning and data-driven approaches.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2023-01-01, Year

Headquarters

Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$4.4M
Last funding
Series A / $4.4M / 2025-09-26
Last equity funding
Series A / $4.4M
Investors
2
Lead investors
1
Articles
2

Categories and groups

No public categories are available.

Founders and investors

Lead investors

DNX Ventures

Investors

DNX VenturesWASEDA University Ventures